Sign in

CIK 0001640266

  • Accelerated filer
  • Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
  1. 4 Grant or award Chief Scientific Officer acquired 38,500 shares (grant or award)
  2. 4 Grant or award Chief Operating Officer acquired 50,000 shares (grant or award)
  3. 4 Grant or award President and CEO acquired 130,000 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
  5. 4 Open-market sale Chief Operating Officer sold 2,543 shares at $7.15 ($18,182)
  6. 4 Open-market sale Chief Scientific Officer sold 1,266 shares at $7.18 ($9,090)
  7. 4 Open-market sale Chief Financial Officer sold 13,567 shares at $6.99 ($94,833)
  8. 4 Grant or award Chief Legal Officer acquired 61,000 shares (grant or award)
  9. 4 Planned sale Chief Scientific Officer sold 10,500 shares at $8.16 ($85,680)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Planned sale Chief Scientific Officer sold 5,500 shares at $10.80 ($59,400)
  13. 4 Planned sale Chief Scientific Officer sold 5,000 shares at $11.41 ($57,050)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 16 · 312 filings